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In individuals with severe spinal cord injury (SCI), the autonomic nervous system (ANS)
is affected leading to cardiovascular deficits, which include significant blood pressure
instability, with the prevalence of systemic hypotension and orthostatic intolerance
resulting in an increased risk of stroke. Additionally, persons with SCI rostral to thoracic
vertebral level 5 (T5), where sympathetic nervous system fibers exit the spinal cord
and innervate the immune system, have clinically significant systemic inflammation and
increased infection risk. Our recent studies show that lumbosacral spinal cord epidural
stimulation (scES), applied at the lumbosacral level using targeted configurations that
promote cardiovascular stability (CV-scES), can safely and effectively normalize blood
pressure in persons with chronic SCI. Herein we present a case report in a female
(age 27 years) with chronic clinically motor complete cervical SCI demonstrating that
97-sessions of CV-scES, which increased systemic blood pressure, improved orthostatic
tolerance in association with increased cerebral blood flow velocity in the middle
cerebral artery, also promoted positive immunological changes in whole-blood gene
expression. Specifically, there was evidence of the down-regulation of inflammatory
pathways and the up-regulation of adaptative immune pathways. The findings of this
case report suggest that the autonomic effects of epidural stimulation, targeted to
promote cardiovascular homeostasis, also improves immune system function, which has
a significant benefit to long-term cardiovascular and immunologic health in individuals
with long-standing SCI.
Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT02307565.
Keywords: spinal cord injury, epidural stimulation, neuromodulation, immune system, orthostatic hypotension,
blood pressure regulation, cerebral blood flow velocity, cardiovascular regulation
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with SCI (Nash et al., 2016; Bloom et al., 2020) and is highest
in individuals with the greatest neurological dysfunction and the
least mobility (Morse et al., 2008; Bloom et al., 2020). Individuals
with the greatest neurological dysfunction have the greatest risk
for infection, and recent studies have demonstrated that the
number of infections during the first year after injury correlates
inversely with neurological recovery in individuals with cervical
SCI (Failli et al., 2012; Brommer et al., 2016; Nash et al.,
2016; Bloom et al., 2020). To better understand the molecular
mechanisms contributing to increased systemic inflammation
and infection risk after SCI, we recently analyzed gene expression
changes in whole blood from individuals with chronic (>12months post-injury) SCI and discovered broad upregulation of
pro-inflammatory genes, in particular the Toll-like Receptor
(TLR) pathway, a key signaling pathway for pathogen recognition
and subsequent activation of innate immunity (Herman and
Bloom, 2018; Herman et al., 2018). Also, we discovered the
decreased expression of genes from natural killer (NK) cells,
which are well-understood to be critical for fighting viral
infections. Both of these molecular observations are significantly
pronounced in individuals with SCI rostral to T5.
Recent findings that describe the use of targeted lumbosacral
epidural stimulation to restore cardiovascular homeostasis (CVscES) in individuals with chronic SCI indicate blood pressure
can be immediately stabilized within a normotensive range for
prolonged periods. Moreover, even when tested without active
stimulation, the improved blood pressure regulation persists, and
orthostatic hypotension is alleviated after 80-sessions of 2-h per
day stimulation in a home setting (Harkema et al., 2018). Active
epidural stimulation in the T11-L1 region in an individual with
chronic C5, motor complete SCI has been reported to increase
cerebral blood flow velocity during head-up tilt (West et al.,
2018); however, the effects of a prolonged CV-scES intervention
on cerebral blood flow velocity during a head-up tilt maneuver
have not been reported. We explored here the effects of a
prolonged CV-scES intervention on blood pressure and cerebral
blood flow regulation and hypothesized that improved ANS
function may also positively impact the immune system. The
goals of this case study were to determine the effects of targeted
CV-scES on orthostatic blood pressure and cerebral blood flow
velocity responses during a head-up tilt maneuver and associated
changes in whole blood gene expression in an individual with
severe, chronic, cervical SCI.

INTRODUCTION
Severe cervical spinal cord injury (SCI) results in multi-organ
system dysfunction that stems, in part, from impaired descending
supraspinal control of the autonomic nervous system (ANS).
As a result of ANS impairment, cardiovascular dysfunction
is common and takes the form of blood pressure instability,
which includes persistent hypotension, orthostatic hypotension,
and autonomic dysreflexia. These blood pressure disorders have
been implicated in an increased prevalence of cerebrovascular
compromise (Saleem et al., 2018), cognitive deficits (Wecht et al.,
2018), and stroke (Wu et al., 2012), which are independent of
symptom reporting in the majority of individuals with SCI. It
is thought that an additional consequence of ANS impairment
is immune system dysfunction (Schwab et al., 2014; Herman
and Bloom, 2018), which promotes systemic inflammation, and
may also play a role in long-term cardiovascular morbidity and
mortality following SCI.
The maladaptive reorganization of the ANS following SCI
is independent of the level of injury as assessed by the
International Standards for the Neurological Classification of
SCI (ISNCSCI; Gimovsky et al., 1985; Currie and Krassioukov,
2015; Katzelnick et al., 2019). Although blood pressure instability
appears to be more prevalent in individuals with cervical
SCI (Claydon and Krassioukov, 2006; Wecht et al., 2013), it
is not exclusive to this group because a critical proportion
of thoracic sympathetic neurons integral to facilitating global
vasomotor control are decentralized by spinal lesions occurring
at or above thoracic vertebral level 1 (T1). Additionally, similar
to astronauts returning from space flight (Convertino, 2009;
Hargens and Richardson, 2009), blood pressure instability in
individuals with SCI at any level may stem from reduced
orthostatic pressure gradients due to the limited amount of
time chronic wheelchair users spend in an upright standing
position (Vaziri, 2003). Importantly, although most individuals
with chronic cervical SCI do not report symptoms associated
with cerebral hypoperfusion, mounting evidence suggests that
asymptomatic daily fluctuations in blood pressure along with
persistent hypotension are associated with reduced cerebral
blood flow velocity in the middle cerebral artery (Phillips et al.,
2014a,b, 2018; Wecht et al., 2017), and cognitive impairments
(Jegede et al., 2010; Phillips et al., 2014b; Wecht et al., 2018).
Individuals with SCI-induced blood pressure instability report
that this condition restricts their participation in daily activities,
and diminishes their independence, vitality, and quality of life
(Weaver et al., 2007; Carlozzi et al., 2013).
After SCI, ANS impairment promotes immune system
dysfunction via diminished descending supraspinal control
and by damage to the sympathetic pre-ganglionic neurons
that innervate immune organs at or below the thoracic level
5 (T5; Schwab et al., 2014; Herman and Bloom, 2018),
which also corresponds to sympathetic neuronal innervation
of cardiovascular targets. Two clinically relevant aspects of
immune dysfunction after SCI are systemic inflammation and
increased risk of infection. Chronic systemic inflammation,
which promotes the risk of cardiovascular disease and stroke in
all populations, is present in more than 75% of individuals living
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MATERIALS AND METHODS
One individual (female, 26.9 years old, 3.1 years from initial
SCI) with chronic cervical motor-complete (C4, AIS grade A)
SCI who presented with significant cardiovascular dysfunction
was implanted with a 16-electrode array epidural stimulator
(RestoreAdvanced, Medtronic) on the dura between spinal
segments L1–S1 at the T11-L1 vertebral level (Figure 1).
Parameters for CV-scES, including electrode polarity, frequency,
and pulse width (Figure 1), were optimized to maintain systolic
blood pressure within a normative range of 110–120 mmHg
(Figure 1) without eliciting lower extremity or core muscle
activation (Figure 1). The participant was instructed to use
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FIGURE 1 | Site of implantation of the electrode array and stimulating configuration for cardiovascular stability-spinal cord epidural stimulation (CV-scES). (A)
Sagittal and Axial MRI sections of the lumbosacral cord were used to calculate the cross-sectional area of the spinal cord and cerebrospinal fluid to create a 3-D
reconstruction of the spinal cord at the lumbosacral enlargement. (B) Sagittal x-rays indicating the final placement of the electrode array. (C) 3-D reconstruction of
the electrode array relative to the lumbosacral enlargement. (D) Graphical representation of electrode configuration for CV-scES, configuration uses two programs
(P1 and P2) running concurrently. Cathodes are represented in black and anodes in gray. Each program runs with an independent stimulating amplitude, pulse width,
and frequency.

this electrode configuration at home throughout 97-sessions.
Hemodynamic and immunological data were obtained before
(pre) and after (post) the CV-scES intervention without active
use of the stimulator during data collection. Data for the preCV-scES intervention were obtained before surgery. Data for the
post-CV-scES intervention were obtained at least 24-h after the
last stimulation session.

occupational therapy, including bed mobility, upright sitting,
and upper extremity exercises. After 15 days as an inpatient at
the rehabilitation hospital, the individual expressed interest in
continuing in the research study. After medical clearance by her
physiatrist, the study-physician, and the Data Safety Monitoring
Board, the individual resumed study participation 53-days after
the accident occurred.

Medical History

Hemodynamic Data Acquisition

The individual sustained a cervical SCI from a motor vehicle
accident at 24 years of age. Hardware was implanted to fuse
the C6 vertebrae after initial SCI and was later revised due
to the hardware-related infection. Medication history before
study enrollment included Gabapentin for neurological pain,
Oxybutynin Chloride for neurogenic bladder, and Methenamine
Hippurate for prophylactic urinary tract infection prevention;
the individual was gradually weaned from Gabapentin before
surgery with guidance from her physiatrist but was allowed to
continue the use of Oxybutynin Chloride and Methenamine
Hippurate. In her medical history, the individual reported
antibiotic treatment for recurrent urinary tract infections, that
occurred at an average rate of ten times per year. There was
no history of cardiovascular or pulmonary disease unrelated to
SCI, but she reported persistent low blood pressure, episodic
orthostatic hypotension, and decreased respiratory functional
performance. Three months post-surgery and after only 12
CV-scES training sessions, the individual was struck by an
oncoming car and sustained an intertrochanteric fracture of
the left femur; after which, participation in the research study
was placed on medical hold. The femur fracture was surgically
repaired with an intramedullary Gamma nail and hip screw.
The individual was an inpatient for a total of 14 days and was
discharged to a rehabilitation hospital with recommendations
to add Eliquis to her daily medications after developing
a pulmonary embolism after surgery. At the rehabilitation
hospital, the individual participated in standard physical and

Hemodynamic assessments were recorded in the morning
in a quiet, temperature-controlled room. The participant
was instructed to avoid consuming caffeine, alcohol, and
nicotine products for at least 12-h and asked to empty her
bladder upon arrival. Instrumentation was applied supine
and included a three-lead ECG (Finapres Medical Systems,
Amsterdam, Netherlands); beat-to-beat blood pressure
recorded from the index finger, middle finger, or thumb using
photoplethysmography (Finapres Medical Systems, Amsterdam,
Netherlands); and transcranial Doppler (TCD) ultrasound of
the middle cerebral artery (Terumo Cardiovascular Systems
1311 Valencia Avenue Tustin, CA 92780-6447, USA). Brachial
blood pressure was recorded (GE Healthcare, Milwaukee,
WI, USA) to calibrate beat-to-beat blood pressure offline
(Bos et al., 1996).
The middle cerebral artery was insonated through the left
temporal window at a frequency of 2.0 MHz. The middle cerebral
artery was identified by the target depth (45–55 mm), sound
and direction of flow (i.e., towards the probe), the characteristic
spectral waveform, and relatively faster flow velocity compared
with surrounding cerebral vessels. Once the middle cerebral
artery was visualized, probe placement was secured for the
duration of testing using a head-harness. Data output from
the TCD was monitored in real-time and included systolic
flow velocity, diastolic flow velocity, and mean flow velocities,
recorded in centimeters per second (cm/s); quality control
for TCD recordings was implemented by identifying a clear
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a fold change greater than 1.5, using the step-up method of the
Benjamini–Hochberg method to correct p values with a false
discovery rate (FDR) = 0.05 (Partek Genomics Flow). Principal
components analysis (PCA) was performed using default
parameters for the determination of the component number,
with all components contributing equally (Partek Genomics
Flow). Component loadings for each comparison examined can
be found in Supplementary Table 1. For functional analysis of
differentially expressed genes, if multiple transcripts for the same
gene symbol were differentially expressed, then the transcript
with the lowest p-value for that gene symbol by were included for
further analyses. Lists of differentially expressed genes for each
comparison examined can be found in Supplementary Table 1.
For functional analysis of differentially expressed genes,
if multiple transcripts or RNA sequences for the same gene
were differentially expressed, then the transcript with the
lowest significant p-value was selected for directionality and
further analyses.
Individual differentially expressed genes of interest are
described below. Functional analysis of all differentially
expressed genes (using unique gene symbols) in a particular
comparison was performed using Enrichr (Chen et al., 2013),
as we have done previously (Herman et al., 2018) to compare
samples from able-bodied with samples from individuals
with SCI (obtained before scES intervention), and within this
research study to compare samples obtained pre and postCV-scES intervention. Enrichr is an online platform that hosts
independent gene-set libraries, or bioinformatics tools, that can
be used to analyze functions of differentially expressed genes
based on published scientific literature and publicly available
data sets (Chen et al., 2013). Broadly speaking, the tools are
divided into categories that characterize the function(s) of genes
queried according to their known roles in signaling pathways,
gene ontologies (GO; Ashburner et al., 2000; Carbon et al., 2019),
cell types, or other functions such as transcription factors. While
each bioinformatics tool may vary concerning specific naming of
individual categories of enriched genes, biological meaning can
be inferred when there is a thematic agreement across multiple
independent platforms.

waveform, characterized by an upstroke to systolic peak and
gradual decline to diastolic trough.
Acute orthostatic stress was induced with a passive, head-up
tilt to 70◦ using a Hi-Lo Tilt Table (Hausman Industries, Inc.,
Northvale, NJ, USA). The individual was strapped to the bed
at the tibial tuberosity, iliac crest, and below the axilla with
her feet against the footplate. The individual rested quietly for
5 min in the supine position and then the bed was tilted to 70◦ ,
during which time blood pressure, ECG, and cerebral blood flow
velocity were recorded continuously. The individual remained in
the head-up tilt position for 30-min or until symptom-limited,
in which case the test was immediately terminated. The head-up
tilt test was performed before implantation and after 97-sessions
of the CV-scES intervention; both assessments were performed
without active CV-scES.

Hemodynamic Data analysis
Digitized blood pressure and heart rate signals were analyzed
with a custom program (MATLAB, The Mathworks, Natick,
MA, USA) that performed R-peak detection of ECG, and
peak and trough detection of the blood pressure waveform.
Systemic mean arterial pressure (MAP) was calculated from
the finger waveform as [systolic blood pressure + (2∗ diastolic
blood pressure)]/3. Flow velocities of the middle cerebral artery
were analyzed offline using a custom program written with
LabVIEW graphical software (National Instruments, Austin TX,
USA). Cerebral mean arterial pressure (cMAP) was estimated
as the difference between systemic MAP and the hydrostatic
pressure gradient calculated between the heart and the head
(i.e., 17.8 mmHg). Mean cerebral blood flow velocity (mCBFv)
was calculated from the integrated TCD signal over each cardiac
cycle. The cerebrovascular conductance index was calculated as
mCBFv/cMAP; cerebral autoregulatory function was estimated
as the correlation coefficient between mCBFv and cMAP.

Immunological Acquisition and Analysis
Blood for gene expression analysis was drawn from a butterfly
catheter inserted into an antecubital vein pre and post-CVscES intervention. Up to 8 ml of whole blood were collected
in PAXgene tubes and stored at −20◦ C until analysis. Total
RNA was isolated by QIAcube, using the manufacturer’s protocol
(Qiagen, Venlo, Netherlands). RNA quality was determined
on the Agilent Bioanalyzer, mRNA-Seq libraries were prepared
(Illumina TruSeq Stranded Total RNA with RiboZero Globin,
Catalog #20020612) and 100 bp paired-end reads were collected
on the Illumina HiSeq 2500 platform (Yale Center for Genome
Analysis). Using Partek Genomics Flow software (St. Louis,
MO, USA), trimmed reads were aligned using STAR to the
human genome (hg38 genome assembly), filtered for expression
>50, normalized using the Trimmed Mean of M-values (TMM)
method using the edgeR package embedded in Partek Genomics,
and log2 transformed. For an initial comparison with a sample
size of convenience, mRNA-Seq libraries were also prepared
from three able-bodied individuals (N = 2 males, one female;
ages 63, 64, and 66, respectively). Transcripts that were
differentially expressed according to the between or withinparticipant(s) comparisons described below were identified with
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RESULTS
Hemodynamic Data
Application of 97-sessions of CV-scES targeted to increase
systolic blood pressure resulted in substantially improved
cardiovascular and cerebrovascular responses during
the head-up tilt maneuver. Orthostatic tolerance to 70◦
head-up tilt improved dramatically: from 10-min preCV-scES intervention to the full 30-min post-CV-scES
intervention. Compared to pre-CV-scES intervention,
improved orthostatic tolerance during head-up tilt postCV-scES intervention was associated with increased cMAP
(from 48.1 ± 13.3 to 51.8 ± 14.6 mmHg, respectively;
Figure 2A) and increased mCBFv (from 28.0 ± 3.8 to
30.5 ± 3.2 cm/s, respectively; Figure 2B). Indeed, the slope
of the relationship between cMAP and mCBFv pre CV-scES
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FIGURE 2 | Mean arterial pressure (MAP) and cerebral blood flow during the orthostatic challenge are improved with CV-scES. (A) Cerebral mean arterial pressure
(cMAP), (B) mean cerebral blood flow (mCBFv) during the head-up tilt maneuver, and (C) relationship between cMAP and mCBFv pre CV-scES (black circles) and
post CV-scES (gray squares). Note that the participant was only able to tolerate 10-min in the 70◦ head-up tilt position pre-CV-scES, but was able to tolerate 30-min
post-CV-scES.

intervention (0.32 cm∗ s−1 *mmHg−1 ) was decreased compared
with post CV-scES intervention (0.16 cm∗ s−1 *mmHg−1 ;
Figure 2C). Changes to blood pressure while resting were
minimal (pre-CV-scES: 112 ± 2.3/73 ± 2.3 mmHg; post-CVscES: 114 ± 2.6/75 ± 1.6 mmHg).

at the molecular level, highlighted MHCII protein complex
binding (GO: 0023026), which is part of the antigen presentation
molecular machinery, as enriched among downregulated
transcripts. Interestingly, cellular level analysis using the
ARCHS4 tissues platform also identified the downregulation of
genes enriched in NK Cells (2.45-Log10 p-value) of the innate
immune system, which are critical for maintaining anti-viral
immunity (Figure 3D). The Human Gene Atlas independently
identified downregulated genes as highly enriched for CD56+
NK Cells transcripts (20.10, −Log10 p-value; Figure 3D).
Multiple bioinformatics platforms identified pathways enriched
among upregulated genes that were related to both eukaryote
and viral transcription and translation, as well as cell cycle
genes and pro-inflammatory genes (Figure 3E). By platform,
these included: REACTOME = viral mRNA Translation (RHSA-192823), WIKI = cytoplasmic ribosomal proteins (WP477),
NCI-Nature = signaling events mediated by focal adhesion kinase
(8fb80085-6195-11e5-8ac5-06603eb7f303), KEGG = Ribosome,
Panther = De novo pyrimidine deoxynucleotide synthesis
(P02739), BioCarta = Cyclin E destruction pathway. Gene
Ontology (GO) analysis using the Biological Process platform
highlighted viral gene expression (GO: 00190980), as enriched
among downregulated transcripts. GO analysis using the
Molecular Function platform highlighted RNA binding (GO:
0003723), which part of the antigen presentation machinery,
as enriched among downregulated transcripts. Cellular level
analysis using the ARCHS4 tissues platform also identified
the upregulation of genes enriched in blood dendritic cells
(Figure 3F), which are highly potent antigen-presenting cells
that link the innate and adaptive immune system. The Human
Gene Atlas identified upregulated genes as highly enriched
for CD71+ (transferrin receptor) early erythroid progenitors
(Figure 4F) and CD105+ endothelial cells (5.12 −Log10 p-value),
among others.
We next analyzed changes in gene expression in the
participant with SCI in response to CV-scES. After 97-sessions
daily CV-scES, interestingly, 397 differentially expressed genes
were observed compared with pre-CV-scES intervention, with
50 upregulated and 347 downregulated unique gene symbols
(Figures 4A,B). At the gene level, several key pro-inflammatory
genes of interest were downregulated, such as members of

Immunological Results and Discussion
We first analyzed major variations in whole blood gene
expression in blood obtained pre CV-scES intervention from the
individual with chronic SCI compared with able-bodied (AB)
individuals. This is illustrated by principal component analysis
(Figure 3A, Supplementary Table 1), where the first component
explained 61.88% of the total variation in gene expression.
Compared to uninjured individuals, in the sample obtained from
the individual with SCI before CV-scES intervention, there were
a total of 4019 differentially expressed unique genes (FDR = 0.05).
Of these, there were 1,535 up- and 2,485 down-regulated genes in
the individual with chronic SCI compared with able-bodied (AB)
data (Figure 3B). We used multiple independent bioinformatics
platforms to identify common functional themes among
pathways enriched in the genes differentially expressed in
the individual with SCI after usual care compared to the AB
data. Interestingly, multiple bioinformatics platforms identified
downregulated pathways that were related to adaptive immunity,
antigen processing, and presentation, which is consistent with
a clinical phenotype of immunosuppression (Figure 3C).
By platform, these were: REACTOME = adaptive immune
system (R-HSA-1280218), WIKI = B cell receptor signaling
pathway (WP23), NCI-Nature = IL2-mediated signaling events
(a2a1883c-6193-11e5-8ac5-06603eb7f303), KEGG = antigen
processing and presentation, Panther = T cell activation
(P00053), BioCarta = role of MEFD in T-cell Apoptosis. The
Gene Ontology (GO) platform (Ashburner et al., 2000; Carbon
et al., 2019), which categorizes known functions of biological
molecules by drawing on data from many species, was used to
analyze the enrichment of differentially expressed genes using
the Biological Process ontology, which describes how genes
contribute to multiple biological processes (geneontology.org).
highlighted regulation of gene expression related to T
cell receptor signaling (GO: 0050852), as enriched among
downregulated transcripts. GO analysis using the Molecular
Function platform, which describes gene-related activities
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FIGURE 3 | Whole blood gene expression is profoundly changed in an individual with spinal cord injury (SCI) compared with able-bodied (AB) individuals.
(A) Principal component analysis (PCA) shows patterns of gene expression. Black symbols represent data obtained from three AB individuals, each sampled once.
Red symbols represent data obtained from the individual with chronic SCI, pre and post CVscES intervention. PCA gene expression in the individual with SCI is
similar pre- and post-intervention along the Y -axis (PC2) and X-axis (PC1), but is different on the Z-axis (PC3) axis. (B) The number of differentially expressed genes
(up- or down-regulated) is shown. (C) Downregulated genes: multiple bioinformatics platforms independently identified pathways enriched following usual care in the
participant with SCI, which are related to adaptive immunity. (D) Two cell type bioinformatics platforms identified natural killer (NK) cell genes enriched among
downregulated genes. (E) Upregulated genes: multiple bioinformatics platforms independently identified pathways enriched following usual care in the participant
with SCI that are related to viral and eukaryotic transcription and translation. (F) Two cell type bioinformatics platforms identified dendritic cells and CD71+ early
erythroid progenitor cells genes enriched among upregulated genes.

the MAP kinase family, TLRs-1, 2, and 4, and LY96, which
interacts with TLR4 (Figure 4A). As with the analysis above,
we used several independent bioinformatics platforms to
identify pathways of genes that were differentially expressed
post-CV-scES intervention compared with pre-CV-scES
intervention within the individual with SCI. Interestingly,
multiple bioinformatics platforms identified downregulated

Frontiers in Systems Neuroscience | www.frontiersin.org

pathways related to the pro-inflammatory TLR signaling, which
is critical for pathogen sensing by the innate immune system
(Figure 4C). By platform, these were: REACTOME = Activated
TLR signaling (R-HSA-166054), WIKI = SCI pathway (WP2431),
NCI-Nature = endogenous TLR signaling (d8777e16-6191-11e58ac5-06603eb7f303), KEGG = tuberculosis, Panther = Toll
receptor signaling pathway (P00054), BioCarta = Toll-like
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FIGURE 4 | Whole blood gene expression is profoundly changed within an individual with SCI after 80 sessions of CV scES. (A) The volcano plot shows several
differentially expressed genes within the participant following 97-sessions of CV-scES. Downregulated genes (green) include pro-inflammatory genes of interest, such
as JAK2, RHOA, and toll-like receptors (TLRs). Upregulated genes (red) include genes of interest related to adaptive immunity, e.g., CD44 and HLA related molecules
(MHCI and MHCII). (B) The numbers of differentially expressed genes are shown. (C) Downregulated genes: multiple bioinformatics platforms independently
identified pathways related to pro-inflammatory TLR signaling. (D) Cell type bioinformatics platforms identified whole blood and dendritic cells enriched among
downregulated genes. (E) Upregulated genes: multiple bioinformatics platforms independently identified pathways related to adaptive immunity. (F) Two cell type
bioinformatics platforms identified peripheral blood and CD14+ monocytes enriched among upregulated genes.

receptor pathway. Gene Ontology (GO) analysis using the
Biological Process platform highlighted TLR signaling (GO:
0002224), as enriched among downregulated transcripts. GO
analysis using the Molecular Function platform also highlighted
TLR binding (GO: 003525), as enriched among downregulated
transcripts. Also, cellular components analysis using the

Frontiers in Systems Neuroscience | www.frontiersin.org

ARCHS4 tissues platform identified the downregulation of genes
enriched in the potent antigen-presenting cells, dendritic cells
(21.00 −Log10 p-value;). The Human Gene Atlas identified
downregulated genes as highly enriched for whole blood
transcripts (67.7, −Log10 p-value; Figure 4D). Multiple
bioinformatics platforms identified pathways enriched among
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regulation, increased orthostatic tolerance, and improved cMAP
and mCBFv responses during a head-up tilt maneuver even
when assessed without stimulation during testing. There was
also a reduction in the slope of the relationship cMAP and
mCBFv during head-up tilt, suggesting improved cerebral
autoregulation post-CV-scES intervention. Further, after the
CV-scES intervention, genes related to adaptive immunity
were upregulated, while genes related to TLR signaling were
downregulated across multiple bioinformatics platforms, which
would be consistent with improved immunity and reduced
systemic inflammation, respectively. These improvements that
persist post-CV-scES intervention without active stimulation
suggest daily use of targeted CV-scES has a beneficial impact on
multiple organ systems that are regulated by the ANS.
Spinal cord epidural stimulation has a long history for
use in treating pain beginning in the 1960s (Shealy et al.,
1967), which was FDA-approved in 1989, and has been shown
to improve microvascular circulation in peripheral vascular
disease (Jacobs et al., 1988). Epidural stimulation of the
lumbosacral motor circuitry has been studied experimentally
in animals (Gerasimenko, 2002) as well as in humans for
spasticity and to understand network circuitry for locomotion
following SCI (Dimitrijevic et al., 1998; Hargens and Richardson,
2009; Harkema et al., 2016; Grahn et al., 2017; Rejc et al.,
2017a,b; Angeli et al., 2018). This approach takes advantage
of sophisticated spinal networks below the level of injury to
unexpectedly reactivate spared pathways, restoring supraspinal
connectivity and resulting in functional recovery in those initially
diagnosed clinically as motor complete (Rejc et al., 2017b,
Calvert et al., 2019).
Investigators recently discovered that specific cardiovasculartargeted scES configurations (CV-scES, L1-S4/5 spinal cord),
that did not elicit motor activity in individuals with SCI who
report cardiovascular dysfunction, could increase and stabilize
orthostatic blood pressure during the orthostatic challenge
(Harkema et al., 2018; West et al., 2018; Darrow et al., 2019),
and mitigate symptoms reporting associated with orthostatic
intolerance. An interesting and novel finding from these
studies was that orthostatic blood pressure was maintained
after 80-sessions of CV-scES in 4 participants with chronic
severe motor complete SCI, even with the stimulator turned off,
which suggests that targeted CV-scES may facilitate adaptive
neuroplasticity to restore endogenous ANS function (Harkema
et al., 2018). Two recent case studies confirm the cardiovascular
autonomic benefits following a single session of targeted scES
in response to an orthostatic challenge (West et al., 2018;
Darrow et al., 2019). Furthermore, improvement in cerebral
blood flow velocity and cognitive function was reported during
a 70◦ head-up tilt maneuver in a female participant with
cardiovascular deficits in response to epidural stimulation of the
thoracolumbar cord.
Profiling of whole blood gene expression in this individual
pre-CV-scES intervention demonstrated molecular signatures
consistent with reduced adaptive immune responses, as
we saw previously in a larger cohort of individuals with
chronic SCI (N = 31) vs. able-bodied persons (N = 26;
Herman et al., 2018). For example, multiple pathway

upregulated genes that were related to adaptive immunity,
including antigen processing and presentation (Figure 4E). By
platform, these included: REACTOME = antigen presentation:
folding, assembly and peptide loading of class I MHC (R-HSA983170), WIKI = ebola virus pathway on the host (WP4217)
which included the class I and II MHC molecules HLAA, HLA-B and HLA-DR, NCI-Nature = integrin signaling
(5d4f90b6-6188-11e5-8ac5-06603eb7f303), KEGG = antigen
processing and presentation, Panther = integrin signaling
pathway (P00034), BioCarta = antigen processing and
presentation. GO analysis using the Biological Process
platform highlighted the upregulation of gene expression
related to antigen processing and presentation via MHCI
(GO:0002480). GO analysis using the Molecular Function
platform also highlighted antigen presentation via MHCII
(GO: 0023026), as enriched among upregulated transcripts.
Cellular components analysis using the ARCHS4 tissues
platform also identified the upregulation of genes enriched
in peripheral blood (Figure 4F), among others. The Human
Gene Atlas identified upregulated genes as highly enriched in
CD14+ monocytes, among others (Figure 4F). GO analysis
using the Biological Process platform highlighted regulation
of gene expression and cellular response to lipopolysaccharide
(GO: 0071222), a major ligand for TLR4, as enriched among
downregulated transcripts.

Self-reported Results
Following 97-sessions of the CV-scES intervention, the
participant reported that her blood pressure no longer fell
precipitously during daily activities and, as a result, her health
and feelings of vitality improved. Because her blood pressure is
stable and closer to a normotensive range, she reports that she
has gained confidence, independence, and autonomy, allowing
her to: participate in in social gatherings with friends and dating;
return to college to finish a degree she started pre-injury; and feel
a stronger connection within the community. Simple activities
of daily life that previously required assistance have become a
part of her daily routine, including brushing her teeth or her
hair, washing alone in the shower, and applying her makeup
without having to take breaks. Importantly, the participant
was an avid singer before her accident, and she reports that
she has regained the cardiovascular strength and stamina to
allow her to return to singing loudly and to carry notes for an
extended period. Finally, the participant reports significantly
improved health such that she no longer feels ‘‘sick’’ and reported
significantly reduced hospital and doctor’s office visits for upper
respiratory and urinary tract infections. Before the implant, the
participant reported an annual incidence of ten urinary tract
infections. In the 18 months, the individual has been using
the stimulator, she has been diagnosed with and treated for
three urinary tract infections without a change to her bladder
maintenance program.

DISCUSSION
Findings of the current case report demonstrate that prolonged,
targeted CV-scES intervention leads to improved blood pressure
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analysis platforms identified genes related to T and B cell
receptor signaling, required for antigen processing and
presentation, as downregulated compared with able-bodied
persons. Two independent cell type platforms identified
genes enriched in NK cells, which are critical for killing
virally infected cells, as downregulated, as well as general
PBMC genes and other T and B cell genes. These findings of
downregulated genes are consistent with a clinical phenotype
of increased infection susceptibility. Pre CV-scES intervention,
genes that were upregulated compared with able-bodied
persons were related to eukaryotic and viral transcription
and translation. In contrast, within the individual with
SCI post-CV-scES intervention, genes related to adaptive
immunity were upregulated across multiple bioinformatics
platforms, which would be consistent with improved
immunity. Interestingly, after CV-scES, downregulated
genes were related to TLR signaling, a pathway that
is critical for pathogen sensing by the innate immune
system and promotes inflammation, which we previously
identified as upregulated in individuals with chronic SCI
(Herman et al., 2018). This would be consistent with reduced
systemic inflammation.
There are several limitations to this proof-of-concept
case report, including this is a report of effects in a
single individual and therefore need to be validated in
studies with a larger number of patients, the longer-term
duration of effects is unknown, the optimal stimulation
parameters for immune-related responses is unknown, and
there may be unknown potential confounders that influence
the observed effects. While defining the mechanisms that
underlie this immune response to targeted epidural stimulation
is beyond the scope of this case-report, this should be
explored in future studies. Several pre-clinical studies in SCI
have shown that an intact sympathetic nervous system is
critical for proper immune function (Schwab et al., 2014).
Furthermore, pre-clinical studies and clinical trials have shown
that the parasympathetic nervous system is also critical
for regulating inflammation and other aspects of immunity
(Koopman et al., 2016; Pavlov and Tracey, 2017). Similarly,
identifying the ANS changes that are responsible for the
improved systemic and cerebral hemodynamics following
prolonged application of CV-scES is essential and may impact
(directly and indirectly) the observed effects on the immune
system. As this is a single case study, additional efforts
are ongoing to examine whether this effect is consistent
in other participants receiving CV-scES and whether this
effect is specific to a CV-targeted configuration. Despite
these limitations, taken together, these data support the
hypothesis that targeted CV-scES parameters that modulate
blood pressure may elicit other improvements in ANS-regulated
functions, including those that promote beneficial changes in the
immune system.
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